Their data showed that the addition of HMO-2′ FL to milk formula reduced the severity of experimental NEC; specifically, HMO-2′ FL protective effects occurred via restoration of intestinal perfusion through upregulation of eNOS and downregulation of proinflammatory molecules including iNOS [136]. The gene discussed is NOS3; the disease is necrotizing enterocolitis.